Erdosteine

BNF:
3.7
Status:
Grey
Decision Date:
None
 

Comments

 

Brown Drug Classifications

  • 1: Lack of data on effectiveness compared with standard therapy
  • 4: Lack of data on cost-effectiveness compared with standard therapy

search again